GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome (Q47584995)

4 February 2018

title

GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome (English)

1 reference

4 February 2018

author

Nicholas K Foreman

7

1 reference

4 February 2018

author name string

A Alsultan

1

1 reference

4 February 2018

R H Giller

2

1 reference

4 February 2018

D Gao

3

1 reference

4 February 2018

J Bathurst

4

1 reference

4 February 2018

E Hild

5

1 reference

4 February 2018

L Gore

6

1 reference

4 February 2018

A Keating

8

1 reference

4 February 2018

R R Quinones

9

1 reference

4 February 2018

language of work or name

English

0 references

publication date

2 August 2010

1 reference

4 February 2018

Bone Marrow Transplantation

published in

1 reference

4 February 2018

volume

46

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

668-675

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1038/bmt.2010.174

exact match

0 references

cites work

Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Donor selection for unrelated cord blood transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

New classification of chronic GVHD: added clarity from the consensus diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

SAS and R functions to compute pseudo-values for censored data regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Pathophysiology of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

7 January 2021

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

7 January 2021

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

7 January 2021

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

7 January 2021

Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

7 January 2021

Feasibility of NIH consensus criteria for chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

7 January 2021

Transplantation of ex vivo expanded cord blood

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

7 January 2021

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

7 January 2021

Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.174

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.174

1 reference

4 February 2018

1 reference

4 February 2018